STIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.419500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.390800E-01
Normal-vs-Stage2
8.812200E-04
Normal-vs-Stage3
9.614400E-01
Normal-vs-Stage4
7.870000E-02
Stage1-vs-Stage2
6.517600E-01
Stage1-vs-Stage3
3.198600E-01
Stage1-vs-Stage4
4.444400E-01
Stage2-vs-Stage3
2.149400E-01
Stage2-vs-Stage4
8.123200E-01
Stage3-vs-Stage4
1.564820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.062400E-03
Normal-vs-AfricanAmerican
7.812300E-02
Normal-vs-Asian
1.307950E-01
Caucasian-vs-AfricanAmerican
6.568600E-01
Caucasian-vs-Asian
6.026400E-01
AfricanAmerican-vs-Asian
3.548400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.755030E-04
Normal-vs-Female
3.051200E-01
Male-vs-Female
1.523790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.297800E-01
Normal-vs-Age(41-60Yrs)
3.41130000003353E-06
Normal-vs-Age(61-80Yrs)
3.224800E-01
Normal-vs-Age(81-100Yrs)
3.152400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.392600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.392200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.160400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.377900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.906610E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.200000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.304000E-01
Normal-vs-Daily Drinker
1.585730E-02
Normal-vs-Weekly Drinker
3.308000E-02
Normal-vs-Occasional Drinker
2.159000E-03
Normal-vs-Social Drinker
3.360400E-02
Non Drinker-vs-Daily Drinker
3.763000E-01
Non Drinker-vs-Weekly Drinker
3.685000E-01
Non Drinker-vs-Occasional Drinker
3.696300E-02
Non Drinker-vs-Social Drinker
2.384600E-01
Daily Drinker-vs-Weekly Drinker
9.414600E-01
Daily Drinker-vs-Occasional Drinker
2.739600E-01
Daily Drinker-vs-Social Drinker
7.172200E-01
Weekly Drinker-vs-Occasional Drinker
3.559600E-01
Weekly Drinker-vs-Social Drinker
7.899000E-01
Occasional Drinker-vs-Social Drinker
5.507600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.453200E-01
Normal-vs-Grade 2
9.317600E-01
Normal-vs-Grade 3
9.943400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.093350E-01
Grade 1-vs-Grade 3
1.011880E-02
Grade 1-vs-Grade 4
8.453200E-01
Grade 2-vs-Grade 3
2.012000E-01
Grade 2-vs-Grade 4
9.317600E-01
Grade 3-vs-Grade 4
9.943400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.878400E-03
Normal-vs-NonDiabetic
4.047500E-04
Diabetic-vs-NonDiabetic
4.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.773100E-04
Normal-vs-NoPancreatitis
1.417890E-03
Pancreatitis-vs-NoPancreatitis
9.742200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.843050E-01
Normal-vs-N1
6.586500E-04
N0-vs-N1
9.283000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.224400E-04
Normal-vs-TP53-NonMutant
5.661400E-01
TP53-Mutant-vs-TP53-NonMutant
2.92239999999389E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
